| Shire
Shire
General counsel, company secretary | Diageo
Chief counsel | Financial Services Compensation Scheme
Team size: 15 Major legal advisers: Addleshaw Goddard, Bevan Brittan, Burges Salmon, Burness Paull, Clifford Chance, Dentons and Eversheds Sutherland What are the most important transactions, litigations, or other major...
Vice president and general counsel | Acklands-Grainger
Kevin Derbyshire, vice president and general counsel at industrial supply company Acklands-Grainger, is responsible for all legal matters and, as of October, 2013, the company’s corporate global real estate and...
| Shire
Shire is a major international biopharmaceutical company with a presence across much of the world. This, and the highly regulated nature of the market sector the company operates in, means...
| Shire
Shire’s Eurasia Middle East and Africa legal function is headquartered in Dubai, with team members dotted around Russia, India, Turkey and South Africa. Head counsel Narguiz Birk-Petersen explains that the...
| Shire Pharmaceuticals
With a requirement to keep pace with a changing regulatory regime across the wide remit of Korea, Taiwan, Hong Kong and Southeast Asia, John Yoo is senior counsel at Shire...
Bill Mordan and the inhouse legal team at FTSE 100 pharmaceutical company Shire have – typically for the industry – been mainly occupied with patent litigation during 2017, but have...
Originating from the UK, registered in Jersey, headquartered in Ireland and with an operational base in the US, Shire Pharmaceuticals is a truly global pharmaceutical business whose products include well-known brands such as Vyvanse, Lialda, and Adderall XR. The company conducts business through multiple offices located in Dublin and the US with a manufacturing site based in Massachusetts. Aside from overseeing legal affairs for the Irish business of the company, which is in itself large, its Dublin-based legal unit is paramount in its work on matters that have global implications on Shire’s business. 2018 so far has been a particularly noteworthy year for the team, as it has worked on and provided valuable insight to assist the impending acquisition of Shire by Takeda Pharmaceuticals for $62bn. The team’s lead Irish lawyer, Susan O’Reilly stands out in this year’s research for her advice on this transaction. More generally, her skills in dispute resolution, intellectual property and commercial litigation have been a further cause for praise.
